FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Advanced Accelerator Applications Pluvicto 1 Recall

PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9

Advanced Accelerator Applications USA, Inc. · Millburn, NJ

Risk level
Class III
Reported by FDA
Aug 23, 2023
Recall ID
D-1085-2023
Check your lot numberHow we source this data

Summary

Advanced Accelerator Applications recalled Pluvicto 1 starting Aug 7, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1085-2023 on Aug 23, 2023. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date

Product description

PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9.2 mL Single-dose vial, Manufacturer: Advanced Accelerator Appllications USA, Inc., 57 E. Willow Street NJ 07041, Milburn, USA, NDC 69488-010-61

Lot numbers, UPCs & expiration codes

Lot # LPS230729B-16, Exp 8/3/2023 at 10:00am, LPS230804B-16, Exp 8/9/2023 at 10:00am.

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1085-2023
Classification
Class III
Status
Terminated
Recall initiated
Aug 7, 2023
FDA report date
Aug 23, 2023
Quantity
10
Recall type
Voluntary: Firm initiated
Recalling firm
Advanced Accelerator Applications USA, Inc.

Original FDA data

Every field from FDA enforcement report D-1085-2023, exactly as published.

Show all FDA fields
City
Millburn
State
NJ
Status
Terminated
Country
United States
Event ID
92845
Address
57 E Willow St
Code information
Lot # LPS230729B-16, Exp 8/3/2023 at 10:00am, LPS230804B-16, Exp 8/9/2023 at 10:00am.
Postal code
07041-1416
Report date
Aug 23, 2023
Product type
Drugs
Recall number
D-1085-2023
Classification
Class III
Recalling firm
Advanced Accelerator Applications USA, Inc.
Product quantity
10
Termination date
Mar 12, 2024
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date
Voluntary / mandated
Voluntary: Firm initiated
Product description
PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9.2 mL Single-dose vial, Manufacturer: Advanced Accelerator Appllications USA, Inc., 57 E. Willow Street NJ 07041, Milburn, USA, NDC 69488-010-61
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Aug 7, 2023
Center classification date
Aug 15, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1085-2023, published Aug 23, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls